InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the complete record of transactions filed by Krieger Nancy. Director active across 1 company, notably Talaris Therapeutics, Inc.. In total, 1 filings have been published. Activity tracked since 10 September 2022. The latest transaction was filed on 10 September 2022 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
1 of 1 declaration